Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
03/27/1996 | EP0448644B1 Transdermal estrogen/progestin dosage unit and system. |
03/27/1996 | CN1119414A Stabilised pharmaceutical compositions and methods for preparing same |
03/27/1996 | CN1119413A Cosmetic or topical use of an aqueous dispersion based on non-volatile organopolysiloxanes and an acrylamide or homopolymeric copolymer type cross-linked methacryloyloxyethyl trimethylammonium ...... |
03/27/1996 | CN1119116A Medicine for curing angiocardiopathy and cerebrovascular diseases and preparing process thereof |
03/27/1996 | CN1119106A Specific Reyanling injection and preparing process thereof |
03/27/1996 | CN1119104A 'Yanchuanning' injection for curing animal asthma and preparing process thereof |
03/27/1996 | CN1119103A 'Kangbingwang' injection for treating animal disease and preparing process thereof |
03/27/1996 | CN1119098A Sunning protecting cosmetic composition based on light filing agent efficiency increasing mixture and use of same |
03/27/1996 | CA2159045A1 Process for the preparation of low molecular weight cellulose ethers |
03/27/1996 | CA2159034A1 Method of minimizing hepatic reperfusion injury |
03/27/1996 | CA2158811A1 Calcium dietary supplement |
03/26/1996 | US5502224 Antitumor agents |
03/26/1996 | US5502094 Physiologically acceptable emulsions containing perfluorocarbon ether hydrides and methods for use |
03/26/1996 | US5502081 Compositions for surgical aids formed from reaction of carbodiimide with hyaluronic acid |
03/26/1996 | US5502076 Dispersing agents for use with hydrofluoroalkane propellants |
03/26/1996 | US5502058 Lidocaine and dextromethorphan or dextrophan |
03/26/1996 | US5502056 Stimulant, antisoporific, salt with p-aminobenzoic acid |
03/26/1996 | US5502051 Central nervous system, antispasmodic |
03/26/1996 | US5501863 Contrast media synthesized from polyaldehydes |
03/26/1996 | US5501861 Carbohydrates |
03/26/1996 | US5501860 Hemicellulose binder and product using the same |
03/26/1996 | US5501859 Absorbable magnesium composition and method of using same |
03/26/1996 | US5501858 Rapidly dispersable compositions containing polydextrose |
03/26/1996 | US5501857 Oral nutritional and dietary composition |
03/26/1996 | US5501856 Controlled-release pharmaceutical preparation for intra-ocular implant |
03/26/1996 | US5501849 Emollient composition |
03/26/1996 | CA2062582C Methods and substances for recruiting therapeutic agents to solid tissues |
03/26/1996 | CA2041044C Large intestinal dissociative polypeptide series oral formulation |
03/23/1996 | CA2132690A1 Control and modulation of inflammatory response in humans in need of such control and modulation |
03/21/1996 | WO1996008574A1 Novel implant and novel vector for the treatment of acquired diseases |
03/21/1996 | WO1996008517A1 Water-soluble dextran fatty acid esters and their use as solubilisers |
03/21/1996 | WO1996008289A1 Needle-less parenteral introduction device |
03/21/1996 | WO1996008273A1 Pharmaceutical compositions containing d2o |
03/21/1996 | WO1996008256A1 2',5' phosphorothioate/phosphodiester oligoadenylates and antiviral uses thereof |
03/21/1996 | WO1996008255A1 Transdermal device for delivery of levonorgestrel |
03/21/1996 | WO1996008253A1 Hydrocodone compositions |
03/21/1996 | WO1996008252A1 Codeine containing formulations |
03/21/1996 | WO1996008251A1 Scopolamine plaster |
03/21/1996 | WO1996008245A1 Patch for external use |
03/21/1996 | WO1996008244A1 Eye drops for repairing corneal disturbance |
03/21/1996 | WO1996008243A1 Pharmaceutical preparation containing metformin and a process for producing it |
03/21/1996 | WO1996008238A1 Use of paracellular absorption enhancers such as glucose for enhaincing the absorption of histamine h2-antagonists |
03/21/1996 | WO1996008237A2 Pressure-sensitive adhesive plaster for releasing active substance into the environment of a support |
03/21/1996 | WO1996008236A1 Capsules with internal waterproof coating for containing matrix-adsorbed aqueous (radioactive) solutions and method of preparing said capsules |
03/21/1996 | WO1996008235A1 Preparation of multivesicular liposomes for controlled release of active agents |
03/21/1996 | WO1996008234A1 Container with multi-phase composition for use in diagnostic and therapeutic applications |
03/21/1996 | WO1996008229A2 Matrix for transdermal drug delivery |
03/21/1996 | DE4438989A1 Scopolaminpflaster Scopolaminpflaster |
03/21/1996 | DE4433191A1 Selbstklebendes Pflaster zur Abgabe von Wirkstoff an die Umgebung eines Trägers Self-adhesive patches for the delivery of drug to the environment of a carrier |
03/21/1996 | DE4433101A1 Wasserlösliche Dextranfettsäureester und ihre Verwendung als Solubilisatoren Water-soluble dextran fatty and their use as solubilizers |
03/21/1996 | DE4432757A1 Pharmazeutische Zubereitung enthaltend Metformin und Verfahren zu deren Herstellung Pharmaceutical composition comprising metformin and methods of their production |
03/21/1996 | CA2699271A1 Needle-less parenteral introduction device |
03/21/1996 | CA2199721A1 Pharmaceutical compositions containing d2o |
03/21/1996 | CA2199610A1 Eye drops for repairing repairing corneal damage |
03/21/1996 | CA2158724A1 Transdermally active pharmaceutical composition containing 5-aminolaevulinic acid |
03/20/1996 | EP0701839A2 Therapeutic products containing organic ashes emitting 'far' infrared radiation |
03/20/1996 | EP0701816A2 Percutaneous absorption preparation containing isosolide dinitrate |
03/20/1996 | EP0701815A1 Process for producing powders, granulates or pellets containing active substances and a structure consisting of hydrophilic macromolecules, and use thereof |
03/20/1996 | EP0701704A1 Material to be worn on the eyeball |
03/20/1996 | EP0701609A1 Inhibition of proliferation of vascular smooth muscle cell |
03/20/1996 | EP0701455A1 Plasma-like solution |
03/20/1996 | EP0701451A1 Emulsions as contrast agents and method of use |
03/20/1996 | EP0701449A1 Process for the preparation of an oral solid dosage form containing diclofenac |
03/20/1996 | EP0701443A1 Terfenadine metabolites and their optically pure isomers for treating allergic disorders |
03/20/1996 | EP0701437A1 Multiparticulate pulsatile drug delivery system |
03/20/1996 | EP0701436A1 Process |
03/20/1996 | EP0701435A1 Compositions for boron neutron capture therapy and methods thereof |
03/20/1996 | EP0701434A1 Preparations containing silicon dioxide to improve the taste thereof |
03/20/1996 | EP0656776B1 Multilayer controlled release tablets containing both naproxen and naproxen sodium salt |
03/20/1996 | EP0652744B1 Pharmaceutical compositions for transmucosal delivery of peptides |
03/20/1996 | EP0648102B1 Cosmetic composition in the form of a gelled silicone/water triple water/oil emulsion |
03/20/1996 | EP0605497B1 Medication vehicles made of solid lipid particles (solid lipid nanospheres - sln) |
03/20/1996 | EP0583459B1 Cosmetic or dermatological composition in the form of an oil-in-water dispersion capable of forming composite films |
03/20/1996 | EP0531524B1 Sustained release suppository |
03/20/1996 | CN2222535Y Compound oral capsule |
03/20/1996 | CN2222534Y Magnetic plaster |
03/20/1996 | CN1119019A Compositions and methods for the treatment of immunomediated inflammatory disorders |
03/20/1996 | CN1119014A Benzopyranes as potassium channel openers |
03/20/1996 | CN1118989A Pharmaceutical compositions comprising paracetamol and L-cysteine or a precursor thereof |
03/20/1996 | CN1118988A Sugar- and sodium-free effervescent tablets and granules and process for preparing same |
03/20/1996 | CN1118693A Film made from herbal medicine for curing ametropia |
03/19/1996 | US5500445 Intraocular irrigating and enucleated eyeball preservative composition |
03/19/1996 | US5500416 Percutaneous absorption promoting agent and dermatologic preparation containing the same |
03/19/1996 | US5500415 Process for the preparation of spherules of active principles and emulsions containing the spherules |
03/19/1996 | US5500228 Phase separation-microencapsulated pharmaceuticals compositions useful for alleviating dental disease |
03/19/1996 | US5500227 Immediate release tablet cores of insoluble drugs having sustained-release coating |
03/19/1996 | US5500226 Pharmaceutical composition having analgesic activity |
03/19/1996 | US5500225 Monitoring melatonin levels and administering to compensate for deficiencies |
03/19/1996 | US5500224 Pharmaceutical compositions containing nanocapsules |
03/19/1996 | US5500222 Mixed with monoglyceride permeation enhancer |
03/19/1996 | US5500221 Sustained release suppository |
03/19/1996 | US5500190 Anion exchange resin compositions containing almond paste for taste improvement |
03/19/1996 | US5500161 Protein drug delivery |
03/19/1996 | US5499979 For delivering a drug to an environment |
03/15/1996 | CA2157754A1 Percutaneous absorption preparation |
03/14/1996 | WO1996007641A1 Heterocyclic derivative and medicine |
03/14/1996 | WO1996007440A2 Methods and apparatus for the delivery of solid drug compositions |
03/14/1996 | WO1996007430A1 Therapeutic treatment of clostridium difficile associated diseases |
03/14/1996 | WO1996007429A1 Liquid immunoglobulin formulations |
03/14/1996 | WO1996007428A1 Peptide compositions capable of down regulating an antigen specific immune response |